Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name file name title title grouped question UIN question first answered answering member label
tabling member	label

Search

1010706

registered interest
date	20/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 October to Question 180697, how many NHS patients have received a Freestyle Libre glucose monitoring system to date.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	193441
answer	answer is ministerial correction date of answer 23/11/2018 answer text <p>This information is not held centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/11/2018 14:15:52 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

1008479

registered interest
date	16/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to make flash glucose monitoring technology available to all patients with diabetes across clinical commissioning groups.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	192108
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192109 192110 question first answered 26/11/2018 17:43:55 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

1008480

registered interest
date	16/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the potential savings to the NHS of making flash glucose monitoring technology available to all patients with diabetes across NHS clinical commissioning groups.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	192109
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192108 192110 question first answered 26/11/2018 17:43:55 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

1002602

registered interest
date	06/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his department has made of the (a) level of and (b) reasons for the variation between Clinical Commissioning Groups in the prescription of continuous glucose monitors for young people suffering from type 1 diabetes.
tabling member constituency	Ipswich
tabling member printed	Sandy Martin
uin	188912
answer	answer is ministerial correction date of answer 15/11/2018 answer text <p>The Department has made no assessment. Ultimately it is for clinical commissioning groups, who are primarily responsible for commissioning diabetes services, to meet the requirements of their population. In doing so, they need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, including young people, are based on the available evidence and take into account national guidelines.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/11/2018 12:31:37 answering member 4067 label Biography information for Steve Brine
tabling member	4678 label Biography information for Sandy Martin

989625

registered interest
date	17/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the oral contribution by the Prime Minister on 17 October 2018, if he will publish the procedure for a diabetic to obtain a Freestyle Libre Glucose Monitoring System through the NHS.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	180697
answer	answer is ministerial correction date of answer 22/10/2018 answer text <p>The Regional Medicines Optimisation Committee North, one of four NHS England committees providing guidance on the use of drugs and devices, has issued advice on the use of Freestyle Libre to support clinical commissioning groups (CCGs), suggesting a careful start to its use and data collection to better understand the benefits for patients. However, ultimately it is for CCGs, who are primarily responsible for commissioning diabetes services, to meet the requirements of their population. In doing so, they need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence and take into account national guidelines.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/10/2018 16:26:17 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

987882

registered interest
date	15/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of patients with Type 1 diabetes had access to (a) an insulin pump, (b) a continuous glucose monitoring device and (c) other devices for measuring blood glucose levels in each clinical commissioning group area in the last 12 months.
tabling member constituency	Knowsley
tabling member printed	Mr George Howarth
uin	179118
answer	answer is ministerial correction date of answer 23/10/2018 answer text <p>This information is not held centrally by the Department or NHS England but is collected individually by clinical commissioning groups.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/10/2018 16:47:29 answering member 4067 label Biography information for Steve Brine
tabling member	481 label Biography information for Sir George Howarth

987887

registered interest
date	15/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of the use of artificial pancreas devices for the treatment of people with Type 1 diabetes.
tabling member constituency	Knowsley
tabling member printed	Mr George Howarth
uin	179123
answer	answer is ministerial correction date of answer 23/10/2018 answer text <p>Artificial pancreas devices are an emerging technology. The Medtronic 670G, currently available in the United States of America, is also soon to become available in the United Kingdom. This is a hybrid artificial pancreas device that provides some automated insulin delivery between meals and overnight, but still requires manual insulin delivery with food. Some supporting data are available which suggest that the device can increase the time period in which glucose values are within target range.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/10/2018 16:54:12 answering member 4067 label Biography information for Steve Brine
tabling member	481 label Biography information for Sir George Howarth

988474

registered interest
date	15/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the answer by the Earl of Courtown on 9 October (HL Deb, cols 9–11), how they are encouraging Clinical Commissioning Groups, including Southwark Clinical Commissioning Group, to make available free flash glucose monitoring devices.
tabling member printed	Lord Morris of Aberavon
uin	HL10673
answer	answer is ministerial correction date of answer 29/10/2018 answer text <p>In January 2018, NHS England issued guidance in the form of a letter, dated 30 January 2018, to clinical commissioning groups (CCGs) concerning the provision of glucose monitoring devices. The guidance states that the treatment of diabetes and the provision of glucose monitoring devices is a service commissioned by individual CCGs. Local CCGs are responsible for deciding how they allocate resources dependant on the needs of their local population. A copy of this letter is attached.</p><p><strong> </strong></p><p>The South East London Area Prescribing Committee, of which NHS Southwark CCG is a member, has published an updated interim position statement relating to FreeStyle Libre Flash Glucose Monitoring, which is attached. Mechanisms are currently being put in place to support delivery of a local implementation plan. It is not possible to place an exact date for completion of the local implementation plan. However, it is anticipated that eligible patients will be able to access FreeStyle Libre on the National Health Service in south east London in autumn 2018.</p><p> </p> answering member printed Lord O'Shaughnessy attachment 1 file name NHS England Blood glucose monitoring systems letter.pdf title NHS England Guidance letter 2 file name APC Position statement PS-004 Freestyle Libre FINAL July 2018.pdf title Interim position statement FreeStyle Libre question first answered 29/10/2018 14:29:32 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	565 label Biography information for Lord Morris of Aberavon

985810

registered interest
date	11/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what guidance they will provide to Clinical Commissioning Groups for making available the FreeStyle Libre glucose monitoring system to all diabetics who require it.
tabling member printed	Lord Kirkhope of Harrogate
uin	HL10616
answer	answer is ministerial correction date of answer 23/10/2018 answer text <p>In January 2018, NHS England issued guidance in the form of a letter to clinical commissioning groups (CCGs) concerning the provision of glucose monitoring devices. The guidance states that the treatment of diabetes and the provision of glucose monitoring devices is a service commissioned by individual CCGs. Local CCGs are responsible for deciding how they allocate resources dependant on the needs of their local population. A copy of this guidance has been attached.</p> answering member printed Lord O'Shaughnessy question first answered 23/10/2018 16:21:47 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name NHS England Blood glucose monitoring systems letter.pdf title Letter to CCGs on glucose monitoring devices
tabling member	891 label Biography information for Lord Kirkhope of Harrogate

964009

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effect of clinical commissioning groups' commissioning of FreeStyle Libre glucose monitoring technology on patients' access to that technology throughout England.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	169910
answer	answer is ministerial correction date of answer 06/09/2018 answer text <p>New figures from NHS England indicate that the majority, around 140 out of 195 clinical commissioning groups (CCGs) have now approved FreeStyle Libre or uptake. Earlier this year NHS England wrote to CCGs reminding them of their responsibilities and of the guidance that exists when it comes to flash glucose monitoring, and other treatments for people with type 1 diabetes.</p><p> </p><p>NHS England continues to work with CCGs to encourage them to adopt best practice.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/09/2018 10:33:05 answering member 4067 label Biography information for Steve Brine
tabling member	1538 label Biography information for Rosie Cooper